What Researchers Did
Researchers looked back at records from 60 people with sudden hearing loss and compared blood cell ratios with those of 30 healthy people, then compared patients who did and did not receive hyperbaric oxygen therapy on top of steroid treatment.
What They Found
In this retrospective study of 60 patients with sudden sensorineural hearing loss and 30 healthy controls, neutrophil/lymphocyte and platelet/lymphocyte ratios were significantly higher in patients at diagnosis and fell significantly after treatment (p less than 0.05). The 60 patients were split into two groups of 30 based on whether they received hyperbaric oxygen (HBO) in addition to combined corticosteroid treatment. The HBO group had larger drops in both ratios than the group without HBO, but only the drop in the neutrophil/lymphocyte ratio was statistically significant (p less than 0.05). A higher platelet/lymphocyte ratio was linked to a lower rate of hearing recovery.
What This Means for Canadian Patients
For people with sudden sensorineural hearing loss, this study suggests that blood ratios such as the platelet/lymphocyte ratio may help predict how well hearing recovers. The abstract reports changes in blood ratios in the HBO group, not hearing outcomes by treatment group, so it does not show whether HBO improves hearing. Patients should talk with their ear, nose and throat doctor about their own situation.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The study was retrospective and done at one tertiary center, so it cannot prove that HBO caused the changes in blood ratios, and the abstract does not give details of the HBO protocol such as pressure or number of sessions.